Vital Signs - The Analyst's Perspective - May 2015 Issue

Share this:
Published: 30 Jun 2015

This issue of Vital Signs, released on June 8, 2015, discusses cholesterol lowering drugs from Amgen and Sanofi/Regeneron, LabCorp's new offering of direct-to-consumer testing, Apple's foray into collecting genetic information from users, and Danaher's acquisition of Pall.



Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..